Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Albireo Pharma, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 100 | 99 | −1 |
| Shares | 16.7M | 15.6M | −1.16M (−6.9%) |
| Value | $589.8M | $546.1M | −$43.6M (−7.4%) |
New holders (8)
Institutions that held Albireo Pharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 20,935 | $736.0K | 0.00% |
| Virtu Financial LLC | 14,969 | $527.0K | 0.05% |
| Boothbay Fund Management, LLC | 7,954 | $280.0K | 0.01% |
| Grimes & Company, Inc. | 7,421 | $261.0K | 0.01% |
| HRT Financial LP | 7,236 | $254.0K | 0.00% |
| ExodusPoint Capital Management, LP | 6,534 | $230.0K | 0.00% |
| Invesco Ltd. | 5,828 | $205.0K | 0.00% |
| State of Wyoming | 35 | $1.00K | 0.00% |
Sold out (9)
Institutions that held Albireo Pharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Cormorant Asset Management, LP | 500,000 | $17.6M |
| Heartland Advisors Inc | 70,000 | $2.47M |
| Engineers Gate Manager LP | 30,407 | $1.07M |
| California Public Employees Retirement System | 27,100 | $955.0K |
| Ikarian Capital, LLC | 16,883 | $595.0K |
| Ameriprise Financial Inc | 13,361 | $471.0K |
| DuPont Capital Management Corp | 6,488 | $229.0K |
| SG Americas Securities, LLC | 3,277 | $116.0K |
| Pacer Advisors, Inc. | 1,151 | $41.0K |